Dexcom (DXCM) Total Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Total Liabilities data on file, last reported at $3.7 billion in Q1 2026.

• On a quarterly basis, Total Liabilities fell 18.03% year-over-year to $3.7 billion in Q1 2026; TTM through Mar 2026 was $3.7 billion, a 18.03% decrease from a year earlier, with the FY2025 full-year figure at $3.6 billion, down 17.98% from the prior year.
• Total Liabilities for Q1 2026 stood at $3.7 billion, up from $3.6 billion in the prior quarter.
• Over the last five years, Total Liabilities for DXCM reached as high as $4.8 billion in Q3 2025 and fell as low as $2.9 billion in Q1 2022.
• Historically, Total Liabilities has averaged $4.0 billion across 5 years, with a median of $4.2 billion in 2024.
• Across the five-year window, Total Liabilities soared 59.39% in 2023 and slipped 18.03% in 2026, its largest moves.
• Year by year, Total Liabilities stood at $3.3 billion in 2022, then advanced by 28.71% to $4.2 billion in 2023, then rose by 4.43% to $4.4 billion in 2024, then declined by 17.98% to $3.6 billion in 2025, then advanced by 2.3% to $3.7 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $3.7 billion in Q1 2026, $3.6 billion in Q4 2025, and $4.8 billion in Q3 2025.